Healthpeak Properties (DOC)
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-09-04
$20.65-1.81%
Close 2026-09-04 · 1-day change
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-09-04
Intact: The reason to own it still holds.
Healthpeak Properties has stable earnings with EPS guidance raised to $0.48 for 2026. The company reaffirms its 2026 FFO guidance at $1.68 to $1.72 per share. Revenue growth is modest but steady at about 1.7% expected for 2026. The balance sheet is strong, supporting growth and dividend payments near 6%.
Revenue growth is very low at about 1.7%, limiting upside. The stock trades at a high PE of 84.4, which is expensive versus peers. EPS estimates have been lowered recently, signaling risk to earnings. Any sustained decline in NOI or FFO would pressure dividends and valuation.
The price is about 1% above our fair value near $21. Analysts expect roughly 1.7% revenue growth in 2026. Our fair value aligns with the Street median, reflecting modest growth and stable income. We see limited upside beyond current expectations.
Breaks if: Significant deterioration in credit ratings or liquidity
Breaks if: EPS falls below $0.46 in FY26
Breaks if: FFO per share falls below $1.68 in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a stable growth opportunity in the real estate sector, particularly focused on senior housing. The current thesis state is intact, supported by recent strong financial performance and management's strategic priorities.
The valuation is considered expensive compared to peers, with the market pricing in a slight expectations gap. This suggests that investors may already be factoring in the company's recent successes and future growth potential.
Fundamentals are likely to show mixed results, with strong growth in senior housing but only modest growth in same-store cash NOI. Management's focus on capital recycling and expansion efforts is expected to support overall stability.
The long-term thesis hinges on key factors such as the Fed's interest rate decisions and performance from sector peers. A credibility hit from any negative guidance changes could significantly impact sentiment.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: Revenue growth falls below 1.7% in FY26
Overall, DOC's position appears stable, but it faces challenges from sector dynamics and interest rate movements. Not investment advice.